Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Change in Receivables (2022 - 2025)

GE HealthCare Technologies (GEHC) has disclosed Change in Receivables for 4 consecutive years, with $210.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Receivables fell 18.6% year-over-year to $210.0 million, compared with a TTM value of $216.0 million through Dec 2025, up 37.58%, and an annual FY2025 reading of $216.0 million, up 37.58% over the prior year.
  • Change in Receivables was $210.0 million for Q4 2025 at GE HealthCare Technologies, up from $191.0 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $258.0 million in Q4 2024 and bottomed at -$165.0 million in Q1 2024.
  • Average Change in Receivables over 4 years is $48.6 million, with a median of $32.0 million recorded in 2024.
  • The sharpest move saw Change in Receivables crashed 850.0% in 2024, then surged 664.0% in 2025.
  • Year by year, Change in Receivables stood at $124.0 million in 2022, then decreased by 26.61% to $91.0 million in 2023, then soared by 183.52% to $258.0 million in 2024, then fell by 18.6% to $210.0 million in 2025.
  • Business Quant data shows Change in Receivables for GEHC at $210.0 million in Q4 2025, $191.0 million in Q3 2025, and -$104.0 million in Q2 2025.